Position in HLN
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$173,640
-$798,020 QoQ
Shares Held
18,611
-80.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#307
of 639 holders
Holding Since
Sep 2022
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in HLN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026RITHOLTZ WEALTH MANAGEMENT holds $18,229,387 across 17 Drug Manufacturers - Specialty & Generic names. HLN ranks #16 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INDV |
Indivior Pharmaceuticals, Inc.
|
121,304 | $4,977,103 | |
| 2 | VTRS |
Viatris Inc
|
200,979 | $3,191,546 | |
| 3 | AMRX |
Amneal Pharmaceuticals, Inc.
|
101,808 | $1,762,296 | |
| 4 | IRWD |
Ironwood Pharmaceuticals Inc
|
360,094 | $1,515,995 | |
| 5 | ALKS |
Alkermes plc.
|
25,487 | $1,335,518 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
|
1,905 | $1,032,186 | |
| 7 | BHC |
Bausch Health Companies Inc.
|
181,540 | $894,992 | |
| 8 | TEVA |
Teva Pharmaceutical Industries Ltd
|
20,490 | $694,201 |
All Filings in HLN
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $173,640 | 18,611 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $971,660 | 97,069 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $448,762 | 44,388 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $702,234 | 78,287 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $686,670 | 66,217 | Shares | Sole | 2025-07-28 | |
| 2025-03-31 | $473,484 | 46,014 | Shares | Sole | 2025-04-17 | |
| 2024-12-31 | $564,901 | 59,214 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $274,709 | 25,965 | Shares | Sole | 2024-10-10 | |
| 2022-09-30 | $61,137 | 10,039 | Shares | Sole | 2022-10-19 | |
| No filing history on record for this holder in this stock. | ||||||